Studying the myelin oligodendrocyte glycoproteins has be found that [Asn31(Glc)]hMOG(30–50) glycoprotein is able to differentiate the serum of MS positive patients from the serum of MS negative ones, recognizing the autoantibodies developed by MS patients. This evidence concerns the gene OMG and myeloid sarcoma.